Chevy Chase Trust Holdings, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1462020
BETHESDA, MD
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$182,016,401
-$3,119,048 QoQ
Shares Held
407,615
-0.2% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Chevy Chase Trust Holdings, LLC holds $389,793,054 across 7 Biotechnology names. VRTX ranks #1 (46.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
407,615 | $182,016,401 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
205,833 | $159,034,808 | |
| 3 | ASND |
Ascendis Pharma A/S
|
123,467 | $28,240,606 | |
| 4 | MRNA |
Moderna, Inc.
|
171,318 | $8,702,954 | |
| 5 | INCY |
Incyte Corp
|
82,356 | $7,751,346 | |
| 6 | TECH |
BIO-TECHNE Corp
|
77,075 | $4,027,939 | |
| 7 | CRBU |
Caribou Biosciences, Inc.
|
10,000 | $19,000 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $182,016,401 | 407,615 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $185,135,449 | 408,363 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $163,904,863 | 418,509 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $196,300,700 | 440,927 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $214,798,530 | 443,048 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $179,081,092 | 444,701 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $207,826,113 | 446,861 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $212,531,240 | 453,429 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $185,523,287 | 443,825 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $181,045,298 | 444,949 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $149,750,058 | 430,638 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $146,357,257 | 415,894 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $106,735,948 | 338,769 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $62,384,854 | 216,029 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $45,363,099 | 156,673 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $43,543,317 | 154,524 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $39,983,734 | 153,212 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $33,543,899 | 152,750 | Shares | Defined | 2022-01-31 | |
| 2021-09-30 | $28,892,887 | 159,286 | Shares | Defined | 2021-10-20 | |
| 2021-06-30 | $33,259,271 | 164,952 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $37,492,287 | 174,472 | Shares | Defined | 2021-04-22 | |
| 2020-12-31 | $44,621,936 | 188,804 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $56,102,979 | 206,170 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $64,214,539 | 221,193 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $54,431,299 | 228,751 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||